Revance Therapeutics, Inc. v. Medy-Tox, Inc. > Summary
Court Case Number IPR2021-01203
Filing Date Jul 1, 2021
Institution Decision Date Jan 19, 2022
Decision Date Jan 19, 2022
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesZhenyu Yang, Timothy G. Majors, Devon J. Zastrow Newman
Judge Writing the Final DecisionZhenyu Yang
Claims Challenged in the Petition: 1, 2, 5, 6, 7, 8, 9, 10, 13, 14
Petitioner
Patent Owner
Petitioner Attorneys
6Revance Therapeutics
Attorney Name: Dennies Varughese
Sterne, Kessler, Goldstein & Fox
Revance Therapeutics
Attorney Name: Olga A. Partington
Sterne, Kessler, Goldstein & Fox
Revance Therapeutics
Attorney Name: Curtis Ruegg
NANOTICS, LLC
Revance Therapeutics
Attorney Name: Sylvia Hall-Ellis
San José State University
Revance Therapeutics
Attorney Name: Andreas Rummel
Revance Therapeutics
Patent Owner Attorneys
4Medytox Inc.
Attorney Name: Edward R. Gates
Wolf, Greenfield & Sacks
Medytox Inc.
Attorney Name: Jonathan B. Roses
Wolf, Greenfield & Sacks
Medytox Inc.
Attorney Name: Brooke Lunn
Wolf, Greenfield & Sacks
Medytox Inc.
Attorney Name: Ashwani Singh
Wolf, Greenfield & Sacks
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09480731 | Long lasting effect of new botulinum toxin formulations | Nov 1, 2016 |
